Skip to main content
. 2020 Dec 1;27(6):e552–e559. doi: 10.3747/co.27.6563

TABLE I.

Characteristics of 76 patients at the time of diagnosis (Dx) of metastatic (stage IV) disease

Characteristic Value
Age (years)
 Median 60
 Range 31–92

Sex [n (%) men] 37 (49)

Ethnicity [n (%)]
 East or Southeast Asian 36 (47)
 White 29 (38)
 Other 11 (14)

Smoking status [n (%) never-smoker] 15 (20)

Education [n (%) no postsecondary] 22 (29)

Employment [n (%) employed] 32 (42)

Marital status [n (%) married] 53 (70)

ecog PS
 0 26 (34)
 1 38 (50)
 2 4 (5)
 Not available 8 (11)

Histology [n (%) adenocarcinoma] 71 (93)

First-line drug [n (%) tki] 44 (58)

First encounter drug [n (%)]
 Tyrosine kinase inhibitor 32 (42)
 Chemotherapy 6 (8)
 At Dx or not on treatment 38 (50)

Sites of metastasis at first encounter [n (%)]
 0 13 (17)
 1 28 (37)
 ≥2 35 (46)
 Pleura 22 (29)
 Lymph node 25 (33)
 Brain 23 (30)
 Liver 9 (12)
 Bone 26 (34)
 Adrenal gland 2 (3)

ecog PS = Eastern Cooperative Oncology Group performance status.